Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lineage Commitment01:21

Lineage Commitment

3.0K
Commitment is the  process whereby stem cells:
3.0K
Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.2K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.2K
Methods of Nuclear Reprogramming01:24

Methods of Nuclear Reprogramming

1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.7K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.7K
Forced Transdifferentiation01:28

Forced Transdifferentiation

1.9K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Programming human cell fate: overcoming challenges and unlocking potential through technological breakthroughs.

Development (Cambridge, England)·2023
Same author

GATA2 mitotic bookmarking is required for definitive haematopoiesis.

Nature communications·2023
Same author

The 2022 International Society for Stem Cell Research (ISSCR) Annual Meeting: Celebrating 20 Years of Achievements.

Cellular reprogramming·2022
Same author

Novel Interplay between p53 and HO-1 in Embryonic Stem Cells.

Cells·2021

Related Experiment Video

Updated: Jul 19, 2025

De Novo Generation of Somatic Stem Cells by YAP/TAZ
13:05

De Novo Generation of Somatic Stem Cells by YAP/TAZ

Published on: May 7, 2018

9.1K

Unleashing Ascl1: Exploring Cross-Lineage Potential in Reprogramming and Regenerative Frontiers.

Camila Vazquez Echegaray1

  • 1Department of Laboratory Medicine, Division of Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Wallenberg Centre for Molecular Medicine, Lund University, Lund, Sweden.

Cellular Reprogramming
|August 17, 2023
PubMed
Summary

The transcription factor Ascl1 shows surprising versatility, reprogramming non-neural cells into diverse lineages beyond its known neural function. This discovery advances stem cell research and regenerative medicine potential.

Keywords:
Ascl1Mef2cdirect reprogrammingepigeneticsregulator

More Related Videos

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
09:29

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Published on: March 22, 2017

7.5K
Live Imaging Followed by Single Cell Tracking to Monitor Cell Biology and the Lineage Progression of Multiple Neural Populations
10:55

Live Imaging Followed by Single Cell Tracking to Monitor Cell Biology and the Lineage Progression of Multiple Neural Populations

Published on: December 16, 2017

8.7K

Related Experiment Videos

Last Updated: Jul 19, 2025

De Novo Generation of Somatic Stem Cells by YAP/TAZ
13:05

De Novo Generation of Somatic Stem Cells by YAP/TAZ

Published on: May 7, 2018

9.1K
Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts
09:29

Assessing Cardiomyocyte Subtypes Following Transcription Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts

Published on: March 22, 2017

7.5K
Live Imaging Followed by Single Cell Tracking to Monitor Cell Biology and the Lineage Progression of Multiple Neural Populations
10:55

Live Imaging Followed by Single Cell Tracking to Monitor Cell Biology and the Lineage Progression of Multiple Neural Populations

Published on: December 16, 2017

8.7K

Area of Science:

  • Stem cell biology
  • Regenerative medicine
  • Molecular biology

Background:

  • Understanding cellular reprogramming is key for regenerative medicine.
  • Ascl1 (Achaete-scute family basic helix-loop-helix transcription factor 1) is primarily known for its role in neurogenesis.
  • The regulatory networks governing cell fate determination are complex.

Purpose of the Study:

  • To investigate the cross-lineage potential of Ascl1.
  • To compare regulatomes (the complete set of DNA-binding sites for a transcription factor) across diverse cell lineages.
  • To explore Ascl1's role beyond neurogenesis in cellular reprogramming.

Main Methods:

  • Comparative analysis of regulatomes from different cell types.
  • Experimental manipulation of Ascl1 expression.
  • Assessment of cell lineage conversion efficiency.

Main Results:

  • Ascl1 demonstrated the ability to reprogram non-neural cells into various lineages, not just neural fates.
  • The study identified conserved and lineage-specific regulatory elements targeted by Ascl1.
  • Ascl1's regulatome varies significantly across different cell types, explaining its diverse potential.

Conclusions:

  • Ascl1 possesses broader lineage reprogramming potential than previously understood.
  • Ascl1 may act as a master regulator for multiple cell fate conversions.
  • These findings open new possibilities for therapeutic cell generation in regenerative medicine.